Global (United States, European Union and China) Alpha 1 Antitrypsin Deficiency Treatment Market Research Report 2019-2025

Publisher Name :
Date: 27-Aug-2019
No. of pages: 126
Inquire Before Buying

Severe deficiency of alpha-1 antitrypsin (AAT) can cause early-onset emphysema and several liver diseases, including cirrhosis, neonatal hepatitis and hepatocellular carcinoma.

The discovery of the structure and function of the AAT protein and the subsequent isolation and purification thereof have made possible alternative therapies aimed at preventing the progression of related pulmonary diseases (so-called "additional therapies"). The isolation of this gene and the advancement of gene therapy have further increased the possibility of specific treatment. Most specific treatments for AAT deficiency aim to increase plasma AAT levels (and thus elevated AAT concentrations in the interstitial lung) above the protection threshold. Other experimental therapeutic approaches attempt to interfere with the production of abnormal AAT proteins or to inhibit the polymerization of abnormal AAT proteins and to promote the secretion of AAT from hepatocytes. For patients with end-stage lung disease or liver disease, organ transplantation is another treatment option.

Currently, the most direct and effective way to increase AAT levels in plasma and interstitial lung is by intravenous infusion of pooled alpha-1 antitrypsin (pAAT).

In 2019, the market size of Alpha 1 Antitrypsin Deficiency Treatment is 1190 million US$ and it will reach 2560 million US$ in 2025, growing at a CAGR of 10.1% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Alpha 1 Antitrypsin Deficiency Treatment.

This report studies the global market size of Alpha 1 Antitrypsin Deficiency Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Alpha 1 Antitrypsin Deficiency Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

- Pfizer

- Baxter

- AstraZeneca

- Grifols

- Teva Pharmaceutical Industries

- Boehringer Ingelheim

- Kamada Ltd

- GlaxoSmithKline

- CSL Behring

- Shire

- LFB Biomedicaments

- Abeona Therapeutics

- Biogen

- Applied Genetic Technologies

- Baxalta

- Arrowhead Research Corporation

- ProBioGen

- Chiesi Pharmaceuticals

- Curaxys

- ProMetic Life Sciences

Market Segment by Product Type

- Augmentation Therapy

- Bronchodilators

- Corticosteroids

- Oxygen Therapy

Market Segment by Application

- Hospitals

- Specialty Clinics

- Pharmacies

Key Regions split in this report: breakdown data for each region.

- United States

- China

- European Union

- Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

- To analyze and research the Alpha 1 Antitrypsin Deficiency Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

- To present the key Alpha 1 Antitrypsin Deficiency Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.

- To split the breakdown data by regions, type, companies and applications

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends, drivers, influence factors in global and regions

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Alpha 1 Antitrypsin Deficiency Treatment are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

Global (United States, European Union and China) Alpha 1 Antitrypsin Deficiency Treatment Market Research Report 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth Rate by Type (2019-2025)
1.3.2 Augmentation Therapy
1.3.3 Bronchodilators
1.3.4 Corticosteroids
1.3.5 Oxygen Therapy
1.4 Market Segment by Application
1.4.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Specialty Clinics
1.4.4 Pharmacies
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size
2.1.1 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue 2014-2025
2.1.2 Global Alpha 1 Antitrypsin Deficiency Treatment Sales 2014-2025
2.2 Alpha 1 Antitrypsin Deficiency Treatment Growth Rate by Regions
2.2.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Regions 2014-2019
2.2.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturers
3.1.1 Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturers 2014-2019
3.1.2 Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturers (2014-2019)
3.2.2 Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Alpha 1 Antitrypsin Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.3 Alpha 1 Antitrypsin Deficiency Treatment Price by Manufacturers
3.4 Key Manufacturers Alpha 1 Antitrypsin Deficiency Treatment Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Alpha 1 Antitrypsin Deficiency Treatment Market
3.6 Key Manufacturers Alpha 1 Antitrypsin Deficiency Treatment Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Augmentation Therapy Sales and Revenue (2014-2019)
4.1.2 Bronchodilators Sales and Revenue (2014-2019)
4.1.3 Corticosteroids Sales and Revenue (2014-2019)
4.1.4 Oxygen Therapy Sales and Revenue (2014-2019)
4.2 Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Type
4.3 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Type
4.4 Alpha 1 Antitrypsin Deficiency Treatment Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Application
6 United States
6.1 United States Alpha 1 Antitrypsin Deficiency Treatment Breakdown Data by Company
6.2 United States Alpha 1 Antitrypsin Deficiency Treatment Breakdown Data by Type
6.3 United States Alpha 1 Antitrypsin Deficiency Treatment Breakdown Data by Application
7 European Union
7.1 European Union Alpha 1 Antitrypsin Deficiency Treatment Breakdown Data by Company
7.2 European Union Alpha 1 Antitrypsin Deficiency Treatment Breakdown Data by Type
7.3 European Union Alpha 1 Antitrypsin Deficiency Treatment Breakdown Data by Application
8 China
8.1 China Alpha 1 Antitrypsin Deficiency Treatment Breakdown Data by Company
8.2 China Alpha 1 Antitrypsin Deficiency Treatment Breakdown Data by Type
8.3 China Alpha 1 Antitrypsin Deficiency Treatment Breakdown Data by Application
9 Rest of World
9.1 Rest of World Alpha 1 Antitrypsin Deficiency Treatment Breakdown Data by Company
9.2 Rest of World Alpha 1 Antitrypsin Deficiency Treatment Breakdown Data by Type
9.3 Rest of World Alpha 1 Antitrypsin Deficiency Treatment Breakdown Data by Application
9.4 Rest of World Alpha 1 Antitrypsin Deficiency Treatment Breakdown Data by Countries
9.4.1 Rest of World Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries
9.4.2 Rest of World Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Alpha 1 Antitrypsin Deficiency Treatment
10.1.4 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
10.1.5 Pfizer Recent Development
10.2 Baxter
10.2.1 Baxter Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Alpha 1 Antitrypsin Deficiency Treatment
10.2.4 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
10.2.5 Baxter Recent Development
10.3 AstraZeneca
10.3.1 AstraZeneca Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Alpha 1 Antitrypsin Deficiency Treatment
10.3.4 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
10.3.5 AstraZeneca Recent Development
10.4 Grifols
10.4.1 Grifols Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Alpha 1 Antitrypsin Deficiency Treatment
10.4.4 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
10.4.5 Grifols Recent Development
10.5 Teva Pharmaceutical Industries
10.5.1 Teva Pharmaceutical Industries Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Alpha 1 Antitrypsin Deficiency Treatment
10.5.4 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
10.5.5 Teva Pharmaceutical Industries Recent Development
10.6 Boehringer Ingelheim
10.6.1 Boehringer Ingelheim Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Alpha 1 Antitrypsin Deficiency Treatment
10.6.4 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
10.6.5 Boehringer Ingelheim Recent Development
10.7 Kamada Ltd
10.7.1 Kamada Ltd Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Alpha 1 Antitrypsin Deficiency Treatment
10.7.4 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
10.7.5 Kamada Ltd Recent Development
10.8 GlaxoSmithKline
10.8.1 GlaxoSmithKline Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Alpha 1 Antitrypsin Deficiency Treatment
10.8.4 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
10.8.5 GlaxoSmithKline Recent Development
10.9 CSL Behring
10.9.1 CSL Behring Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Alpha 1 Antitrypsin Deficiency Treatment
10.9.4 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
10.9.5 CSL Behring Recent Development
10.10 Shire
10.10.1 Shire Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Alpha 1 Antitrypsin Deficiency Treatment
10.10.4 Alpha 1 Antitrypsin Deficiency Treatment Product Introduction
10.10.5 Shire Recent Development
10.11 LFB Biomedicaments
10.12 Abeona Therapeutics
10.13 Biogen
10.14 Applied Genetic Technologies
10.15 Baxalta
10.16 Arrowhead Research Corporation
10.17 ProBioGen
10.18 Chiesi Pharmaceuticals
10.19 Curaxys
10.20 ProMetic Life Sciences
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Alpha 1 Antitrypsin Deficiency Treatment Sales Channels
11.2.2 Alpha 1 Antitrypsin Deficiency Treatment Distributors
11.3 Alpha 1 Antitrypsin Deficiency Treatment Customers
12 Market Forecast
12.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales and Revenue Forecast 2019-2025
12.2 Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Type
12.3 Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Application
12.4 Alpha 1 Antitrypsin Deficiency Treatment Forecast by Regions
12.4.1 Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Regions 2019-2025
12.4.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
Figure Alpha 1 Antitrypsin Deficiency Treatment Product Picture
Table Alpha 1 Antitrypsin Deficiency Treatment Key Market Segments
Table Major Manufacturers Alpha 1 Antitrypsin Deficiency Treatment Covered in This Report
Table Global Alpha 1 Antitrypsin Deficiency Treatment Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Shar by Type 2014-2025
Figure Augmentation Therapy Figures
Table Major Manufacturers of Augmentation Therapy
Figure Bronchodilators Figures
Table Major Manufacturers of Bronchodilators
Figure Corticosteroids Figures
Table Major Manufacturers of Corticosteroids
Figure Oxygen Therapy Figures
Table Major Manufacturers of Oxygen Therapy
Table Global Alpha 1 Antitrypsin Deficiency Treatment Market Share by Application 2019-2025 (K Units)
Figure Hospitals Use Case
Figure Specialty Clinics Use Case
Figure Pharmacies Use Case
Figure Alpha 1 Antitrypsin Deficiency Treatment Report Years Considered
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Market Size 2014-2025 (Million US$)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales 2014-2019 (K Units)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Regions 2014-2019 (K Units)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Regions 2014-2019
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Regions 2014-2019
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Regions in 2019
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Regions 2014-2019 (Million US$)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Regions 2014-2019
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Regions 2014-2019
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Manufacturers (2014-2019) (K Units)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Manufacturers (2014-2019)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Manufacturers in 2019
Table Alpha 1 Antitrypsin Deficiency Treatment Revenue by Manufacturers (2014-2019) (Million USD)
Table Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Manufacturers (2014-2019)
Figure Alpha 1 Antitrypsin Deficiency Treatment Value Share by Manufacturers in 2019
Table Global Alpha 1 Antitrypsin Deficiency Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Alpha 1 Antitrypsin Deficiency Treatment Price (2014-2019) (USD/Unit)
Table Key Manufacturers Alpha 1 Antitrypsin Deficiency Treatment Plants/Factories Distribution
Table Key Manufacturers Alpha 1 Antitrypsin Deficiency Treatment Area Served
Table Date of Key Manufacturers Enter into Alpha 1 Antitrypsin Deficiency Treatment Market
Table Key Manufacturers Alpha 1 Antitrypsin Deficiency Treatment Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Augmentation Therapy Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Bronchodilators Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Corticosteroids Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Oxygen Therapy Sales and Revenue (2014-2019) (K Units) & (Million US$)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Type (2014-2019) (K Units)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Type (2014-2019)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Type (2014-2019)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Type in 2018
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue by Type (2014-2019) (Million US$)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Share by Type (2014-2019)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Type (2014-2019)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Type in 2018
Table Alpha 1 Antitrypsin Deficiency Treatment Price by Type 2014-2019 (USD/Unit)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales by Application (2014-2019) (K Units)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Share by Application (2014-2019)
Figure Global Sales Alpha 1 Antitrypsin Deficiency Treatment Market Share by Application (2014-2019)
Figure Global Sales Alpha 1 Antitrypsin Deficiency Treatment Market Share by Application (2014-2019)
Figure United States Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate 2014-2019 (K Units)
Figure United States Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table United States Alpha 1 Antitrypsin Deficiency Treatment Sales by Company (2014-2019) (K Units)
Table United States Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Company (2014-2019)
Figure United States Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Company in 2019
Table United States Alpha 1 Antitrypsin Deficiency Treatment Sales by Type (2014-2019) (K Units)
Table United States Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Type (2014-2019)
Figure United States Alpha 1 Antitrypsin Deficiency Treatment Market Share by Type in 2019
Table United States Alpha 1 Antitrypsin Deficiency Treatment Sales by Application (2014-2019) (K Units)
Table United States Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Application (2014-2019)
Figure United States Alpha 1 Antitrypsin Deficiency Treatment Market Share by Application in 2019
Figure European Union Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate 2014-2019 (K Units)
Figure European Union Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Alpha 1 Antitrypsin Deficiency Treatment Sales by Company (2014-2019) (K Units)
Table European Union Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Company (2014-2019)
Figure European Union Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Company in 2019
Table European Union Alpha 1 Antitrypsin Deficiency Treatment Sales by Type (2014-2019) (K Units)
Table European Union Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Type (2014-2019)
Figure 2018 European Union Alpha 1 Antitrypsin Deficiency Treatment Market Share by Type
Table European Union Alpha 1 Antitrypsin Deficiency Treatment Sales by Application (2014-2019) (K Units)
Table European Union Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Application (2014-2019)
Figure 2018 European Union Alpha 1 Antitrypsin Deficiency Treatment Market Share by Application
Figure China Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate 2014-2019 (K Units)
Figure China Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table China Alpha 1 Antitrypsin Deficiency Treatment Sales by Company (2014-2019) (K Units)
Table China Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Company (2014-2019)
Figure China Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Company in 2019
Table China Alpha 1 Antitrypsin Deficiency Treatment Sales by Type (2014-2019) (K Units)
Table China Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Type (2014-2019)
Figure China Alpha 1 Antitrypsin Deficiency Treatment Market Share by Type in 2019
Table China Alpha 1 Antitrypsin Deficiency Treatment Sales by Application (2014-2019) (K Units)
Table China Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Application (2014-2019)
Figure China Alpha 1 Antitrypsin Deficiency Treatment Market Share by Application in 2019
Figure Rest of World Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate 2014-2019 (K Units)
Figure Rest of World Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Alpha 1 Antitrypsin Deficiency Treatment Sales by Company (2014-2019) (K Units)
Table Rest of World Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Company (2014-2019)
Figure Rest of World Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Company in 2019
Table Rest of World Alpha 1 Antitrypsin Deficiency Treatment Sales by Type (2014-2019) (K Units)
Table Rest of World Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Type (2014-2019)
Figure Rest of World Alpha 1 Antitrypsin Deficiency Treatment Market Share by Type in 2019
Table Rest of World Alpha 1 Antitrypsin Deficiency Treatment Sales by Application (2014-2019) (K Units)
Table Rest of World Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Application (2014-2019)
Figure Rest of World Alpha 1 Antitrypsin Deficiency Treatment Market Share by Application in 2019
Table Rest of World Alpha 1 Antitrypsin Deficiency Treatment Sales by Countries (2014-2019) (K Units)
Table Rest of World Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries (2014-2019)
Figure Rest of World Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share by Countries in 2019
Table Rest of World Alpha 1 Antitrypsin Deficiency Treatment Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries (2014-2019)
Figure Rest of World Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share by Countries in 2019
Figure Japan Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Japan Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (K Units)
Figure Korea Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Korea Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (K Units)
Figure India Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units)
Figure India Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019) (K Units)
Figure Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Revenue Growth Rate (2014-2019) (K Units)
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019)
Table Pfizer Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in Global Market
Table Pfizer Recent Development
Table Baxter Company Details
Table Baxter Description and Business Overview
Table Baxter Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Baxter Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019)
Table Baxter Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in Global Market
Table Baxter Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Description and Business Overview
Table AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019)
Table AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in Global Market
Table AstraZeneca Recent Development
Table Grifols Company Details
Table Grifols Description and Business Overview
Table Grifols Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Grifols Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019)
Table Grifols Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in Global Market
Table Grifols Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Description and Business Overview
Table Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019)
Table Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in Global Market
Table Teva Pharmaceutical Industries Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Description and Business Overview
Table Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019)
Table Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in Global Market
Table Boehringer Ingelheim Recent Development
Table Kamada Ltd Company Details
Table Kamada Ltd Description and Business Overview
Table Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019)
Table Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in Global Market
Table Kamada Ltd Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Description and Business Overview
Table GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019)
Table GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in Global Market
Table GlaxoSmithKline Recent Development
Table CSL Behring Company Details
Table CSL Behring Description and Business Overview
Table CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019)
Table CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in Global Market
Table CSL Behring Recent Development
Table Shire Company Details
Table Shire Description and Business Overview
Table Shire Alpha 1 Antitrypsin Deficiency Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Table Shire Alpha 1 Antitrypsin Deficiency Treatment Sales Growth Rate (2014-2019)
Table Shire Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share in Global Market
Table Shire Recent Development
Table LFB Biomedicaments Company Details
Table Abeona Therapeutics Company Details
Table Biogen Company Details
Table Applied Genetic Technologies Company Details
Table Baxalta Company Details
Table Arrowhead Research Corporation Company Details
Table ProBioGen Company Details
Table Chiesi Pharmaceuticals Company Details
Table Curaxys Company Details
Table ProMetic Life Sciences Company Details
Figure Alpha 1 Antitrypsin Deficiency Treatment Value Chain
Table Alpha 1 Antitrypsin Deficiency Treatment Distributors List
Table Alpha 1 Antitrypsin Deficiency Treatment Customers List
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast 2019-2025 (K Units) & (Million US$)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast 2019-2025 (K Units)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Forecast 2019-2025 (Million US$)
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Type 2019-2025 (K Units)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Type 2019-2025 (K Units)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share Forecast by Type 2019-2025
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Application 2019-2025 (K Units)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Application 2019-2025 (K Units)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share Forecast by Application 2019-2025
Table Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast by Regions 2019-2025 (K Units)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Sales Market Share Forecast by Regions 2019-2025
Table Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Forecast by Regions 2019-2025 (K Units)
Figure Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Market Share Forecast by Regions 2019-2025
Figure United States Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast 2019-2025 (K Units)
Figure United States Alpha 1 Antitrypsin Deficiency Treatment Revenue Forecast 2019-2025 (Million US$)
Figure European Union Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast 2019-2025 (K Units)
Figure European Union Alpha 1 Antitrypsin Deficiency Treatment Revenue Forecast 2019-2025 (Million US$)
Figure China Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast 2019-2025 (K Units)
Figure China Alpha 1 Antitrypsin Deficiency Treatment Revenue Forecast 2019-2025 (Million US$)
Figure Japan Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast 2019-2025 (K Units)
Figure Japan Alpha 1 Antitrypsin Deficiency Treatment Revenue Forecast 2019-2025 (Million US$)
Figure Korea Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast 2019-2025 (K Units)
Figure Korea Alpha 1 Antitrypsin Deficiency Treatment Revenue Forecast 2019-2025 (Million US$)
Figure India Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast 2019-2025 (K Units)
Figure India Alpha 1 Antitrypsin Deficiency Treatment Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Sales Forecast 2019-2025 (K Units)
Figure Southeast Asia Alpha 1 Antitrypsin Deficiency Treatment Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global and United States Amlexanox Market Report & Forecast 2022-2028
    Published: 27-May-2022        Price: US 4350 Onwards        Pages: 75
    Amlexanox market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Amlexanox market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Amlexanox market size by players, by Type and by Application, f......
  • Global and United States Clarithromycin Market Report & Forecast 2022-2028
    Published: 27-May-2022        Price: US 4350 Onwards        Pages: 100
    Clarithromycin market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Clarithromycin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Clarithromycin market size by players, by Type and by......
  • Global and United States Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Report & Forecast 2022-2028
    Published: 27-May-2022        Price: US 4350 Onwards        Pages: 108
    Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this repor......
  • Global and United States Epinephrine Injection Market Report & Forecast 2022-2028
    Published: 27-May-2022        Price: US 4350 Onwards        Pages: 101
    Epinephrine Injection market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Epinephrine Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Epinephrine Injection market size by pl......
  • Global and United States Antigout Drug Market Report & Forecast 2022-2028
    Published: 27-May-2022        Price: US 4350 Onwards        Pages: 103
    Antigout Drug market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Antigout Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Antigout Drug market size by players, by Type and by Ap......
  • Global and United States Endoscopic Vessel Harvesting Market Report & Forecast 2022-2028
    Published: 27-May-2022        Price: US 4350 Onwards        Pages: 87
    Endoscopic Vessel Harvesting market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Endoscopic Vessel Harvesting market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Endoscopic Vessel Harvest......
  • Global and United States Endodontics Market Report & Forecast 2022-2028
    Published: 27-May-2022        Price: US 4350 Onwards        Pages: 100
    Endodontics market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Endodontics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Endodontics market size by players, by Type and by Applicat......
  • Global and United States Empty Capsules Market Report & Forecast 2022-2028
    Published: 27-May-2022        Price: US 4350 Onwards        Pages: 109
    Empty Capsules market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Empty Capsules market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Empty Capsules market size by players, by Type and by......
  • Global and United States Prothrombin Complex Market Report & Forecast 2022-2028
    Published: 27-May-2022        Price: US 4350 Onwards        Pages: 97
    Prothrombin Complex market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Prothrombin Complex market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Prothrombin Complex market size by players,......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs